Humoral immune response Archives - Inside Precision Medicine

Inside Precision Medicine New Test for HER2-Low Expression Could Expand Treatment Options

3D image of breast cancer metastasizing representing HER2 breast cancer.

News & Features

New Test for HER2-Low Expression Could Expand Treatment Options

Malorye Branca -

February 5, 2024

Doctor preparing a vaccine for an injection

Molecular Dx

CellCarta, physIQ Collaborate to Study Individual Responses to Vaccination

Chris Anderson -

March 18, 2022

Vials With the Covid-19 Vaccine and Syringes are Displayed On a Tray at the Corona Vaccination Center

Coronavirus

Valneva’s More Traditional COVID-19 Vaccine Achieves Good Results at Phase III

Helen Albert -

October 19, 2021

Antibodies responding to coronavirus particle, illustration

Coronavirus

Antibody-Producing Cells Last at Least One Year After COVID-19 Infection

Chris Anderson -

May 25, 2021

Antibody proteins attacking coronavirus, illustration

News & Features

Early COVID-19 Antibody Signatures in Patients May Be Predictive of Death or Recovery

Chris Anderson -

August 10, 2020

Related Content

Geneoscopy's RNA-Based Colorectal Cancer Test Approved by FDA

Geneoscopy's RNA-Based Colorectal Cancer Test Approved by FDA

Enlaza Nets $100M to Advance Covalent Biologics Platform

Enlaza Nets $100M to Advance Covalent Biologics Platform

Cancer-Like Features in Atherosclerosis Provide New Opportunity for Treatment

Cancer-Like Features in Atherosclerosis Provide New Opportunity for Treatment

AI That Predicts Targeted Cancer Drug Response with Single-Cell Precision

AI That Predicts Targeted Cancer Drug Response with Single-Cell Precision